Vivimed Labs Limited (NSE:VIVIMEDLAB)

Vivimed Labs Statistics

Total Valuation

Vivimed Labs has a market cap or net worth of INR 582.06 million. The enterprise value is 4.41 billion.

Market Cap	582.06M
Enterprise Value	4.41B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Vivimed Labs has 82.91 million shares outstanding. The number of shares has increased by 0.15% in one year.

Current Share Class	82.91M
Shares Outstanding	82.91M
Shares Change (YoY)	+0.15%
Shares Change (QoQ)	-0.31%
Owned by Insiders (%)	11.57%
Owned by Institutions (%)	6.94%
Float	64.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.53
PB Ratio	-1.21
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 193.53, with an EV/FCF ratio of -19.02.

EV / Earnings	-18.11
EV / Sales	4.05
EV / EBITDA	193.53
EV / EBIT	n/a
EV / FCF	-19.02

Financial Position

The company has a current ratio of 0.78

Current Ratio	0.78
Quick Ratio	0.21
Debt / Equity	n/a
Debt / EBITDA	168.44
Debt / FCF	-16.56
Interest Coverage	-6.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-5.85%
Return on Capital Employed (ROCE)	-4.04%
Weighted Average Cost of Capital (WACC)	1.84%
Revenue Per Employee	1.86M
Profits Per Employee	-415,853
Employee Count	586
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Vivimed Labs has paid 1.13 million in taxes.

Income Tax	1.13M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.97
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	2.46
Average Volume (20 Days)	474,911

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vivimed Labs had revenue of INR 1.09 billion and -243.69 million in losses. Loss per share was -2.94.

Revenue	1.09B
Gross Profit	571.84M
Operating Income	-197.52M
Pretax Income	-242.56M
Net Income	-243.69M
EBITDA	22.80M
EBIT	-197.52M
Loss Per Share	-2.94

Balance Sheet

The company has 10.12 million in cash and 3.84 billion in debt, with a net cash position of -3.83 billion or -46.20 per share.

Cash & Cash Equivalents	10.12M
Total Debt	3.84B
Net Cash	-3.83B
Net Cash Per Share	-46.20
Equity (Book Value)	-479.63M
Book Value Per Share	-5.78
Working Capital	-940.21M

Cash Flow

In the last 12 months, operating cash flow was -228.07 million and capital expenditures -3.88 million, giving a free cash flow of -231.95 million.

Operating Cash Flow	-228.07M
Capital Expenditures	-3.88M
Free Cash Flow	-231.95M
FCF Per Share	-2.80

Margins

Gross margin is 52.46%, with operating and profit margins of -18.12% and -22.36%.

Gross Margin	52.46%
Operating Margin	-18.12%
Pretax Margin	-22.25%
Profit Margin	-22.36%
EBITDA Margin	2.09%
EBIT Margin	-18.12%
FCF Margin	n/a

Dividends & Yields

Vivimed Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.15%
Shareholder Yield	-0.15%
Earnings Yield	-41.87%
FCF Yield	-39.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 6, 2016. It was a forward split with a ratio of 5.

Last Split Date	Apr 6, 2016
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1